DDL can support the full range of activities for tailor-made molecular diagnostic assays, including design, development, and formal analytical and clinical validation. DDL is highly experienced in all phases of assay development, and assays can be custom-made to meet the specific requirements of our clients.
We are very experienced in various technology platforms, including PCR, real-time PCR, reverse transcriptase PCR, microtiterplate-based read-out systems, reverse hybridization formats, Luminex and sequencing. As an alpha-testing site, we can design and develop new assays, conduct proof-of-concept or feasibility studies, and perform evaluations and assay validations, according to the appropriate international guidelines.
Furthermore, we can also serve as a beta-testing site to assist you to optimize your existing assay or perform comparative studies against other assays.
Assays can be efficiently produced by our partner laboratory LBP, an ISO13485 certified small scale production facility.
